Cue Biopharma Inc at Cowen Healthcare Conference (Virtual) Transcript
Good morning. My name is Cynthia, and I'm a member of the biotech team. It's my pleasure to introduce Dan Passeri, the CEO of Cue Biopharma.
Thank you very much. Good morning, everyone. First, I want to thank Cowen for giving us an opportunity to present at their conference.
So Cue is an immunotherapy company dedicated to protein engineering for immune modulation. Our symbol -- NASDAQ symbol is CUE. Just as a reminder, this presentation is being webcast and will be on our web for 30 days after this conference that you can listen to. I'll also reference when -- what slide I'm on.
So next slide is forward-looking statements. This presentation may contain some forward-looking statements.
Now Slide #3. Cue is dedicated to rationally engineering biologics in therapeutics, in essence, harness nature's cues for selective and specific immune modulation. And next couple of slides will be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |